COPD pp 243-260 | Cite as

Non-pharmacologic Management: LVR, Rehabilitation, and Nutrition

  • Sei Won LeeEmail author
  • Eun Mi Kim


Please check the hierarchy of the section headings and confirm if correct.


  1. 1.
    Vestbo J, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347–65.CrossRefGoogle Scholar
  2. 2.
    Lee JH, et al. Responses to inhaled long-acting beta-agonist and corticosteroid according to COPD subtype. Respir Med. 2009;104(4):542–9.PubMedGoogle Scholar
  3. 3.
    Brantigan OC, Mueller E. Surgical treatment of pulmonary emphysema. Am Surg. 1957;23(9):789–804.PubMedGoogle Scholar
  4. 4.
    Brantigan OC, Mueller E, Kress MB. A surgical approach to pulmonary emphysema. Am Rev Respir Dis. 1959;80(1, Part 2):194–206.PubMedGoogle Scholar
  5. 5.
    Cooper JD, et al. Results of 150 consecutive bilateral lung volume reduction procedures in patients with severe emphysema. J Thorac Cardiovasc Surg. 1996;112(5):1319–29. discussion 1329–30PubMedGoogle Scholar
  6. 6.
    Fishman A, et al. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med. 2003;348(21):2059–73.Google Scholar
  7. 7.
    Sciurba FC, et al. A randomized study of endobronchial valves for advanced emphysema. N Engl J Med. 2010;363(13):1233–44.Google Scholar
  8. 8.
    Herth FJ, et al. Efficacy predictors of lung volume reduction with Zephyr valves in a European cohort. Eur Respir J. 2012;39(6):1334–42.PubMedGoogle Scholar
  9. 9.
    Herth FJ, et al. Radiological and clinical outcomes of using Chartis to plan endobronchial valve treatment. Eur Respir J. 2013;41(2):302–8.PubMedGoogle Scholar
  10. 10.
    Hopkinson NS, et al. Atelectasis and survival after bronchoscopic lung volume reduction for COPD. Eur Respir J. 2011;37(6):1346–51.PubMedGoogle Scholar
  11. 11.
    Kotecha S, et al. Long-term outcomes from bronchoscopic lung volume reduction using a bronchial prosthesis. Respirology. 2011;16(1):167–73.PubMedGoogle Scholar
  12. 12.
    Valipour A, et al. Target lobe volume reduction and COPD outcome measures after endobronchial valve therapy. Eur Respir J. 2014;43(2):387–96.PubMedGoogle Scholar
  13. 13.
    Come CE, et al. A randomised trial of lung sealant versus medical therapy for advanced emphysema. Eur Respir J. 2015;46(3):651–62.PubMedPubMedCentralGoogle Scholar
  14. 14.
    Hartman JE, et al. Treatment of emphysema using bronchoscopic lung volume reduction coil technology: an update on efficacy and safety. Ther Adv Respir Dis. 2015;9(5):251–9.PubMedGoogle Scholar
  15. 15.
    Evans RA, Singh SJ, Collier R, Williams JE, Morgan MD. Pulmonary rehabilitation is successful for COPD irrespective of MRC dyspnoea grade. Respir Med. 2009;103(7):1070–5.PubMedGoogle Scholar
  16. 16.
    Man WD, Grant A, Hogg L, Moore J, Barker RD, Moxham J. Pulmonary rehabilitation in patients with MRC Dyspnoea scale 2. Thorax. 2011;66(3):263.PubMedGoogle Scholar
  17. 17.
    Decramer M, Vestbo J, Bourbeau J, Celi B, Hui D, Varela MV, et al. Global strategy for the diagnosis, management and the prevention of chronic obstructive pulmonary disease (updated 2014) . 2014.
  18. 18.
    Bolton CE, Bevan-Smith EF, Blakey JD, Crowe P, Elkin SL, Garrod R, et al. 2013 British Thoracic Society guideline on pulmonary rehabilitation in adults. Thorax. 68 Suppl 2:ii1–i30.Google Scholar
  19. 19.
    Lacasse Y, Martin S, Lasserson TJ, Goldstein RS. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. A Cochrane systematic review. Eura Medicophys. 2007;43(4):475–85.PubMedGoogle Scholar
  20. 20.
    Group CW. Pulmonary rehabilitation for patients with chronic pulmonary disease (COPD): an evidence-based analysis. Ont Health Technol Assess Ser. 2012;12(6):1–75.Google Scholar
  21. 21.
    Lacasse Y, Goldstein R, Lasserson TJ, Martin S. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2006;4:CD003793.Google Scholar
  22. 22.
    Griffiths TL, Burr ML, Campbell IA, Lewis-Jenkins V, Mullins J, Shiels K, et al. Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial. Lancet. 2000;355(9201):362–8.PubMedGoogle Scholar
  23. 23.
    Puhan M, Scharplatz M, Troosters T, Walters EH, Steurer J. Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2009;1:CD005305.Google Scholar
  24. 24.
    Coventry PA, Hind D. Comprehensive pulmonary rehabilitation for anxiety and depression in adults with chronic obstructive pulmonary disease: systematic review and meta-analysis. J Psychosom Res. 2007;63(5):551–65.PubMedGoogle Scholar
  25. 25.
    Emery CF, Schein RL, Hauck ER, MacIntyre NR. Psychological and cognitive outcomes of a randomized trial of exercise among patients with chronic obstructive pulmonary disease. Health Psychol. 1998;17(3):232–40.PubMedGoogle Scholar
  26. 26.
    Stav D, Raz M, Shpirer I. Three years of pulmonary rehabilitation: inhibit the decline in airflow obstruction, improves exercise endurance time, and body-mass index, in chronic obstructive pulmonary disease. BMC Pulm Med. 2009;9:26.PubMedPubMedCentralGoogle Scholar
  27. 27.
    Greening NJ, Williams JE, Hussain SF, Harvey-Dunstan TC, Bankart MJ, Chaplin EJ, et al. An early rehabilitation intervention to enhance recovery during hospital admission for an exacerbation of chronic respiratory disease: randomised controlled trial. BMJ. 2014;349:g4315.PubMedPubMedCentralGoogle Scholar
  28. 28.
    Steele BG, Belza B, Cain K, Warms C, Coppersmith J, Howard J. Bodies in motion: monitoring daily activity and exercise with motion sensors in people with chronic pulmonary disease. J Rehabil Res Dev. 2003;40(5 Suppl 2):45–58.PubMedGoogle Scholar
  29. 29.
    Lareau SC, Carrieri-Kohlman V, Janson-Bjerklie S, Roos PJ. Development and testing of the Pulmonary Functional Status and Dyspnea Questionnaire (PFSDQ). Heart Lung. 1994;23(3):242–50.PubMedGoogle Scholar
  30. 30.
    Lareau SC, Meek PM, Roos PJ. Development and testing of the modified version of the pulmonary functional status and dyspnea questionnaire (PFSDQ-M). Heart Lung. 1998;27(3):159–68.PubMedGoogle Scholar
  31. 31.
    Weaver TE, Narsavage GL, Guilfoyle MJ. The development and psychometric evaluation of the Pulmonary Functional Status Scale: an instrument to assess functional status in pulmonary disease. J Cardpulm Rehabil. 1998;18(2):105–11.Google Scholar
  32. 32.
    Stratton RJ, Green CJ, Elia M. Disease-related malnutrition: an evidence-based approach to treatment. Wallingford: CABI; 2003.Google Scholar
  33. 33.
    Berthon BS, Wood LG. Nutrition and respiratory health-feature review. Forum Nutr. 2015;7:1618–43.Google Scholar
  34. 34.
    Itoh M, Tsuji T, Nemoto K, Nakamura H, Aoshoba K. Undernutrition in patients with COPD and its treatment. Forum Nutr. 2013;5:1316–35.Google Scholar
  35. 35.
    Langen RCJ, Gosker HR, Remels AHV, Schols AMWJ. Triggers and mechanisms of skeletal muscle wasting in chronic obstructive pulmonary disease. Int J Biochem Cell Biol. 2013;45:2245–56.PubMedGoogle Scholar
  36. 36.
    Hallin R, Gudmundsson G, Ulrik CS, Nieminen MM, Gislason T, Linberg E, Brondum E, Aine T, Basle P, Janson C. Nutritional status and long-term mortality in hospitalised patients with chronic obstructive pulmonary disease (COPD). Respir Med. 2007;101:1954–60.PubMedGoogle Scholar
  37. 37.
    American Association of Cardiovascular and Pulmonary Rehabilitation. Guidelines for pulmonary rehabilitation programs, 4th ed. American Association of Cardiovascular and Pulmonary Rehabilitation. 2011.Google Scholar
  38. 38.
    Van der Valk P, Monninkhof E, Van der Palen J, Zielhuis G, Van Herwaarden C. Management of stable COPD. Patient Educ Couns. 2004;52:225–9.PubMedGoogle Scholar
  39. 39.
    Escott-Stump S. Nutrition and diagnosis-related care. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2012.Google Scholar
  40. 40.
    Schols AM, Broekhuizen R, Weling-Scheepers CA, Wouters EF. Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr. 2005;82:53–9.PubMedPubMedCentralGoogle Scholar
  41. 41.
    Burchfiel CM, Enright PL, Sharp DS, Chyou PH, Rodriguez BL, Curb JD. Factors associated with variations in pulmonary function among elderly Japanese-American men. Chest. 1997;112:87–97.PubMedGoogle Scholar
  42. 42.
    Amara CE, Koval JJ, Paterson DH, Cunningham DA. Lung function in older human: the contribution of body composition, physical activity and smoking. Ann Hum Biol. 2001;25:522–36.Google Scholar
  43. 43.
    Academy of Nutrition and Dietetics. Chronic obstructive pulmonary disease toolkit. Academy of Nutrition and Dietetics. 2012.Google Scholar
  44. 44.
    American Society for Parenteral and Enteral Nutrition. The science and practice of nutrition support American Society for Parenteral and Enteral Nutrition: a case based core curriculum. Dubuque: Kendall/Hunt; 2001.Google Scholar
  45. 45.
    Moore JA, Angelillo VA. Equations for the prediction of resting energy expenditure in chronic obstructive lung disease. Chest. 1988;94:1260–3.PubMedGoogle Scholar
  46. 46.
    Width M, Reinhard T. The clinical dietitian’s essential pocket guide. Philadelphia: Lippincott Williams & Wilkins; 2009.Google Scholar
  47. 47.
    Herr C, Greulich T, Koczulla RA, Meyer S, Zakharkina T, Bransch M, Eschmann R, Bals R. The role of vitamin D in pulmonary disease: COPD, asthma, infection, and cancer. Respir Res. 2011;12:31.PubMedPubMedCentralGoogle Scholar
  48. 48.
    Jørgensen NR, Schwarz P. Osteoporosis in chronic obstructive pulmonary disease patients. Curr Opin Pulm Med. 2008;14:122–7.PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2017

Authors and Affiliations

  1. 1.Department of Pulmonary and Critical Care MedicineAsan Medical Center, University of Ulsan College of MedicineSeoulSouth Korea
  2. 2.Department of DieteticsKangbuk Samsung HospitalSeoulSouth Korea

Personalised recommendations